CalculatorGastroenterology and hepatology

NAFLD fibrosis score (NFS)

Estimates the likelihood of advanced fibrosis in non-alcoholic/metabolic fatty liver disease from routine clinical and laboratory data.

Updated 31 October 2026

When to use it

Adults with non-alcoholic fatty liver disease (MASLD) to decide who needs elastography, biopsy or hepatology referral.

What it needs

  • AgeUnits: años
  • Body mass indexUnits: kg/m²
  • Impaired fasting glucose or diabetesYes or no
  • ASTUnits: U/L
  • ALTUnits: U/L
  • PlateletsUnits: ×10⁹/L (= ×10³/µL), /µL
  • AlbuminUnits: g/dL, g/L

Formula

NFS = −1.675 + 0.037 × age + 0.094 × BMI + 1.13 × (IFG or diabetes) + 0.99 × AST/ALT − 0.013 × platelets (×10⁹/L) − 0.66 × albumin (g/dL)

How to interpret it

NFS
ResultInterpretation
< -1.455< −1.455: advanced fibrosis unlikely (F0–F2)
-1.455 to < 0.677−1.455 to 0.676: indeterminate; consider elastography
≥ 0.677> 0.676: advanced fibrosis likely (F3–F4)

Practical tip

Below −1.455 advanced fibrosis is ruled out with high negative predictive value; above 0.676 it is suggested with high positive predictive value.

2 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top